PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.01%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
1.21%
Gross profit growth under 50% of STERV.HE's 3.85%. Michael Burry would be concerned about a severe competitive disadvantage.
5.90%
EBIT growth below 50% of STERV.HE's 152.94%. Michael Burry would suspect deeper competitive or cost structure issues.
5.90%
Operating income growth under 50% of STERV.HE's 152.94%. Michael Burry would be concerned about deeper cost or sales issues.
23.81%
Net income growth under 50% of STERV.HE's 12300.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
19.96%
EPS growth under 50% of STERV.HE's 11438.46%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
19.96%
Diluted EPS growth under 50% of STERV.HE's 11438.46%. Michael Burry would worry about an eroding competitive position or excessive dilution.
3.17%
Share change of 3.17% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.17%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-43.93%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-41.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-26.25%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.25%
Negative 5Y CAGR while STERV.HE stands at 11.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-29.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-32.08%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-32.08%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
139.50%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
124.28%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
124.28%
5Y net income/share CAGR similar to STERV.HE's 123.86%. Walter Schloss might see both on parallel mid-term trajectories.
152.97%
Below 50% of STERV.HE's 362.07%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.21%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.68%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.01%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.69%
Asset growth above 1.5x STERV.HE's 1.73%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.51%
We have a declining book value while STERV.HE shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.26%
Debt shrinking faster vs. STERV.HE's 1.08%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-3.01%
We cut SG&A while STERV.HE invests at 3.46%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.